LRRK2 - Wikipedia
Lee Kimball (@LRK2) / X
LRRK2 kinase in Parkinson's disease
PPM1H is down-regulated by ATF6 and dephosphorylates p-RPS6KB1 to inhibit progression of hepatocellular carcinoma: Molecular Therapy - Nucleic Acids
The Development and Design Strategy of Leucine-Rich Repeat Kinase 2 Inhibitors: Promising Therapeutic Agents for Parkinson's Disease
Frontiers Roles of Long Non-coding RNAs in the Development of Aging-Related Neurodegenerative Diseases
Selective Inhibitors of G2019S-LRRK2 Kinase Activity
Leucine‐rich repeat kinase 2 interacts with p21‐activated kinase 6 to control neurite complexity in mammalian brain - Civiero - 2015 - Journal of Neurochemistry - Wiley Online Library
Is LRRK2 the missing link between inflammatory bowel disease and Parkinson's disease?
Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson's disease
IJMS, Free Full-Text
Lee Kimball (@LRK2) / X
Perspective on the current state of the LRRK2 field